24LifeSciences InsightStream

 According to a newly published market research report by 24LifeSciences , global total foot system market was valued at USD 3.2 billion in 2025  and is projected to reach USD 5.1 billion by 2034 , growing at a compound annual growth rate (CAGR) of 6.8% during the forecast period 2026–2034 . Total foot systems represent a comprehensive orthopedic solution for complex foot pathologies including trauma reconstruction, arthritis management, and severe deformities . These advanced medical systems combine specialized implants, instruments, and fixation devices designed for anatomical restoration across forefoot, midfoot, and hindfoot applications. Their clinical significance continues to grow as they address the increasing global burden of foot-related disabilities. Download a Free Sample Report (PDF):  https://www.24lifesciences.com/download-sample/15035/total-foot-system-market Rising Prevalence of Diabetes and Musculoskeletal Disorders Drives Market Expansion The glo...

 According to a newly published market research report by 24LifeSciences , global all trans retinoic acid market was valued at USD 520 million in 2025  and is projected to reach USD 780 million by 2034 , growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period 2026–2034 . All Trans Retinoic Acid (ATRA), chemically known as tretinoin , is a derivative of vitamin A that plays a crucial role in cellular differentiation and apoptosis . It is clinically proven for treating acute promyelocytic leukemia (APL) and widely prescribed for severe acne, psoriasis, and photoaging . As a nuclear receptor ligand, ATRA regulates gene expression in target cells, making it unique among dermatological and oncological therapeutics. Download a Free Sample Report (PDF):  https://www.24lifesciences.com/download-sample/15061/all-trans-retinoic-acid-market Increasing Dermatological Applications Drive Market Expansion The growing global prevalence of chronic skin condit...

 According to a newly published market research report by 24LifeSciences , global adjunctive hemostat s market was valued at USD 1.8 billion in 2023 and is projected to reach USD 2.7 billion by 2030 , growing at a compound annual growth rate (CAGR) of 5.9% during the forecast period 2024-2030 . Adjunctive hemostats are medical devices designed to control bleeding during surgical procedures when conventional methods prove insufficient. These critical products enhance the body's natural clotting process through mechanical, absorbable, or active biological mechanisms. The market primarily includes gauze-based hemostats, powder formulations, gelatin sponges, and advanced polymer-based solutions , with applications spanning cardiovascular, orthopedic, and general surgeries. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15153/adjunctive-hemostats-market Expanding Surgical Volumes Drive Market Adoption The global increase in surgical proceduresesti...

 According to a newly published market research report by 24LifeSciences , global Graft Versus Host Disease (GVHD) Treatment market was valued at USD 1.2 billion in 2024  and is projected to reach USD 2.1 billion by 2031 , growing at a compound annual growth rate (CAGR) of 8.5% during the forecast period 2025-2031 . Graft versus Host Disease, a serious complication following stem cell or bone marrow transplants, occurs when donor immune cells (the graft) attack the recipient's (host's) tissues. The disease manifests in two forms - acute GVHD (typically occurring within 100 days post-transplant) and chronic GVHD (developing after 100 days). Current treatment approaches include corticosteroids, immunosuppressants, monoclonal antibodies, and emerging cellular therapies. The condition remains a leading cause of morbidity and mortality in transplant recipients, driving significant research and development efforts. Download a Free Sample Report (PDF):  https://www.24lifesci...

 According to a newly published market research report by 24LifeSciences , global immunodiagnostics market was valued at USD 11,660 million in 2024  and is projected to reach USD 17,680 million by 2031 , growing at a compound annual growth rate (CAGR) of 6.3% during the forecast period 20252031 . Immunodiagnostics involves advanced testing methodologies that utilize antigen-antibody reactions to detect diseases, infections, and biochemical markers with high specificity. These solutions play a pivotal role in diagnosing critical conditions across infectious diseases, cancer, autoimmune disorders, and allergies through techniques including ELISA, chemiluminescence immunoassays (CLIA), and rapid diagnostic tests . The technology's ability to provide accurate, early detection continues to revolutionize clinical diagnostics and therapeutic monitoring. Download a Free Sample Report (PDF):  https://www.24lifesciences.com/download-sample/15499/immunodiagnostics-market Rising C...

 According to a newly published market research report by 24LifeSciences , global steroids for pets market was valued at USD 1.16 billion in 2025  and is projected to reach USD 2.04 billion by 2034 , growing at a compound annual growth rate (CAGR) of 6.7% during the forecast period 2026–2034 . Steroids for pets are synthetic compounds administered to companion animals primarily to manage inflammation, allergies, and autoimmune disorders. Key therapeutic categories include glucocorticoids such as prednisone and dexamethasone, as well as sex hormones used for reproductive health management. These medications serve a critical role in veteri nary medicine by reducing inflammation and modulating immune responses in conditions ranging from arthritis to severe allergic reactions. Download a Free Sample Report (PDF):  https://www.24lifesciences.com/download-sample/15086/steroids-for-pets-market Rising Companion Animal Healthcare Expenditure Drives Market Growth The increasing...

 According to a newly published market research report by 24LifeSciences , the global bovine respiratory disease treatment market was valued at USD 39 million in 2024 and is projected to reach USD 133 million by 2031 , growing at a compound annual growth rate (CAGR) of 19.6% during the forecast period 2025-2031 . Bovine Respiratory Disease (BRD), also known as shipping fever or feedlot pneumonia , is a complex respiratory syndrome in cattle caused by viral, bacterial, and environmental factors . The condition accounts for over 70% of feedlot illnesses and remains the most significant cause of economic losses in the cattle industry globally. Treatment options include antibiotics, vaccines, immunomodulators, and supportive therapies targeting pathogens like Mannheimia haemolytica and Bovine Respiratory Syncytial Virus (BRSV) . Download a Free Sample Report (PDF):  https://www.24lifesciences.com/download-sample/15593/bovine-respiratory-disease-treatment-market Increasing Globa...

 According to a newly published market research report by 24LifeSciences , global luliconazole cream market was valued at USD 427 million in 2025 and is projected to reach USD 683 million by 2034 , growing at a compound annual growth rate (CAGR) of 5.8% during the forecast period 2026-2034 . Luliconazole cream is a broad-spectrum antifungal medication belonging to the imidazole class, clinically used to treat dermatophyte infections including athlete's foot, jock itch, and ringworm . As a topical formulation, it works by inhibiting fungal lanosterol 14-demethylase, disrupting ergosterol synthesis in fungal cell membranes. The product's high efficacy and convenient once-daily application continue to drive its adoption across clinical and retail settings. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15009/luliconazole-cream-market Increasing Fungal Infection Prevalence Drives Market Expansion The rising global burden of fungal infections...

 According to a newly published market research report by 24LifeSciences , global RdRp inhibitor market was valued at USD 352.14 million in 2023 and is projected to reach USD 521.68 million by 2028 , growing at a compound annual growth rate (CAGR) of 8.2% during the forecast period 2024-2028 . RNA-dependent RNA polymerase (RdRp) inhibitors represent a critical antiviral therapy class that prevents viral replication by targeting the essential RdRp enzyme. These nucleotide analogs are particularly effective against RNA viruses including SARS-CoV-2, influenza, hepatitis C, and Ebola . The clinical success of therapeutics like remdesivir and molnupiravir during the COVID-19 pandemic has established RdRp inhibitors as frontline antiviral treatments in hospital and outpatient settings. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/14768/rdrp-inhibitor-market Growing Threat of RNA Viruses Drives Market Expansion The increasing prevalence of RNA v...

 According to a newly published market research report by 24LifeSciences , the global smart ambulatory infusion pump market was valued at USD 195 million in 2025 and is projected to reach USD 303 million by 2032 , growing at a compound annual growth rate (CAGR) of 6.6% during the forecast period 2026-2032 . Smart ambulatory infusion pumps are sophisticated, portable medical devices designed to administer therapeutic fluids including medications, nutrients, and chemotherapy drugs outside traditional hospital environments. These advanced systems employ programmable electronic controls, integrated safety alarms, and dosage error reduction software to deliver precise, continuous, intermittent, or patient-controlled therapy. Their capability to support treatments for chronic conditions like autoimmune disorders, cancer, and antibiotic-resistant infections while enabling patient mobility represents a significant advancement in decentralized healthcare delivery. Download a Free Sample...